Dendritic-cell-based therapeutic vaccination against cancer.
about
Cancer vaccines: the next generation of tools to monitor the anticancer immune response.A peptide-loaded dendritic cell based cytotoxic T-lymphocyte (CTL) vaccination strategy using peptides that span SIV Tat, Rev, and Env overlapping reading frames.Immune Cells in Cancer Therapy and Drug DeliveryCancer vaccines: state of the art of the computational modeling approachesThe characterization and role of leukemia cell-derived dendritic cells in immunotherapy for leukemic diseasesEx vivo recovery and activation of dysfunctional, anergic, monocyte-derived dendritic cells from patients with operable breast cancer: critical role of IFN-alpha.Personalized cell-mediated immunotherapy and vaccination: combating detrimental uprisings of malignanciesDendritic cells pulsed with keyhole limpet hemocyanin and cryopreserved maintain anti-tumor activity in a murine melanoma modelOptimization of stability, encapsulation, release, and cross-priming of tumor antigen-containing PLGA nanoparticles.Independent regulation of chemokine responsiveness and cytolytic function versus CD8+ T cell expansion by dendritic cells.PIAS1 and STAT-3 impair the tumoricidal potential of IFN-γ-stimulated mouse dendritic cells generated with IL-15.In situ modulation of dendritic cells by injectable thermosensitive hydrogels for cancer vaccines in miceModular injectable matrices based on alginate solution/microsphere mixtures that gel in situ and co-deliver immunomodulatory factors.Polymer nanoparticles containing tumor lysates as antigen delivery vehicles for dendritic cell-based antitumor immunotherapy.Mechanisms involved in radiation enhancement of intratumoral dendritic cell therapy.Immunization of NSCLC patients with antigen-pulsed immature autologous dendritic cellsImmunotherapy of cancer in 2012.Cross-presentation: underlying mechanisms and role in immune surveillance.Plasma membrane vesicles decorated with glycolipid-anchored antigens and adjuvants via protein transfer as an antigen delivery platform for inhibition of tumor growthImmune privilege induced by regulatory T cells in transplantation tolerance.Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinomaDendritic cell vaccines for leukemia patients.DC-based cancer vaccines.Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in non-small cell lung cancer.Progress and prospects: gene therapy clinical trials (part 2).Harnessing dendritic cells for tumor antigen presentationImmunotherapy for liver tumors: present status and future prospects.Poly(ethylene glycol)-Lipid-Conjugated Antibodies Enhance Dendritic Cell Phagocytosis of Apoptotic Cancer Cells.Comparison the effects of two monocyte isolation methods, plastic adherence and magnetic activated cell sorting methods, on phagocytic activity of generated dendritic cells.Dendritic cell-based therapeutic cancer vaccines: what we have and what we need.Mature dendritic cell derived from cryopreserved immature dendritic cell shows impaired homing ability and reduced anti-viral therapeutic effects.Dendritic cells in immunotherapy of established cancer: Roles of signals 1, 2, 3 and 4Personalized dendritic cell-based tumor immunotherapy.Polarized dendritic cells as cancer vaccines: directing effector-type T cells to tumors.Disarming dendritic cells: a tumor strategy to escape from immune control?Dendritic cell-based vaccines for the therapy of experimental tumors.Dendritic cell preparation for immunotherapeutic interventions.Future therapeutics for the induction of peripheral immune tolerance in autoimmune disease and organ transplantation.Dendritic cell tumor killing activity and its potential applications in cancer immunotherapy.Differentiation and activation of equine monocyte-derived dendritic cells are not correlated with CD206 or CD83 expression.
P2860
Q24814450-1DFE442B-2811-4392-A82B-91C9571DA952Q25255620-A005D58E-A7A0-4461-9FB9-109BFBA4BCE2Q26747061-CF90EE59-DE13-4AD4-B349-FD77A216E78FQ26825044-95AB18DF-36DA-445B-9A88-60B03D01D3D0Q26852652-10F49334-DB65-49F5-9643-21546F711AB8Q33347561-268874A5-5C6A-415B-8CE6-3A700C8C8457Q33361158-9AD7C207-5DFF-439B-B31F-5C245850BFE5Q33614807-045D339F-B0F6-4CC7-804F-14EA392ABD3EQ33821392-B82F3551-8E69-4BEB-A2C0-22C60F7BEA20Q34067493-28DB9F46-FD26-4779-81ED-978272AC454EQ34076409-7B476815-9156-4193-828C-3A85F0682964Q34330250-CF3E8450-2BC2-4311-89B3-A2DA02ADE808Q34588908-2F5F9370-4530-46B9-A8B1-8A2114805959Q34775944-723F624E-C1D7-4A25-958A-3894A3ED5FA4Q35012602-0543C423-DBF7-45A6-A6C1-93A1DCF68DAFQ36116566-B810AE7A-1D7D-46D0-8FCC-5D606258CC3FQ36243536-423E1212-6B8E-4557-B06A-54CC1A727148Q36266474-DCBC315F-CEAC-4D9D-84B8-F47CC4B4E7BAQ36322686-8F6BEEB3-A376-427A-BAF8-8FC46A4519AAQ36593774-CC2C4E5A-B6AA-4DF9-BAF1-7FDE9DB0625EQ36643535-8BD0A6D4-FB1A-4D02-9AA8-DFEA57AA1680Q36752018-B06E07E7-17F5-4564-B9FE-C2E7E26305EEQ36809780-B4C7F03C-8A8E-4D92-A581-80C9E8B662DAQ36828493-18124A2A-B1F4-4657-AE60-1AAF189FE941Q36994170-3CFC0A10-538C-4C48-BC9E-25CC793A1256Q37132747-914CF97E-288C-496F-BF64-EEEAB96627B4Q37144014-BA773760-E59E-49AB-A17A-A7B5EED0CF31Q37148735-6CE3AE65-53B5-4BA7-BEAD-AF50D2B8D89AQ37161763-630EB82E-A388-455B-BBEC-8C5D0AFAB590Q37448957-B870E701-AA08-4EC4-AF3F-30303EBCDB1DQ37497528-C0FA3519-A793-4B10-A21E-31F090752BCCQ37513871-9CB1784E-43E0-40FB-9676-F60CCB579744Q37693733-81B8ADB5-3151-448C-B354-13629872A415Q37735454-F93A7C09-6465-4AD5-82DF-5D18A0ED1538Q37755322-729C3DD4-9E03-4A16-9F12-DDF282665FDDQ37773259-6DA22E6C-0A32-42F7-B4CA-FC9DA6ED4B3DQ37773266-9C5567A3-1CD3-4DD6-A1C5-F1965E3063E4Q37773272-87144DBA-8AF5-4DAE-992F-999F69926B2CQ38091116-61F68A3F-D79A-4814-BACD-767356238C0BQ38317327-A8543BBC-9466-47E8-8CCB-0E93B3135107
P2860
Dendritic-cell-based therapeutic vaccination against cancer.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Dendritic-cell-based therapeutic vaccination against cancer.
@ast
Dendritic-cell-based therapeutic vaccination against cancer.
@en
type
label
Dendritic-cell-based therapeutic vaccination against cancer.
@ast
Dendritic-cell-based therapeutic vaccination against cancer.
@en
prefLabel
Dendritic-cell-based therapeutic vaccination against cancer.
@ast
Dendritic-cell-based therapeutic vaccination against cancer.
@en
P2093
P1476
Dendritic-cell-based therapeutic vaccination against cancer.
@en
P2093
Arpad Farkas
Curdin Conrad
Frank O Nestle
P304
P356
10.1016/J.COI.2005.02.003
P577
2005-04-01T00:00:00Z